Dimethylformamide → HCID 57665977, 화합물
반응식
[CH2:1]([O:3][C:4](=[O:32])[CH:5]([C:10]1[CH:11]=[C:12]([C:22]2[CH:27]=[CH:26][C:25]([C:28]([F:31])([F:30])[F:29])=[CH:24][CH:23]=2)[CH:13]=[C:14]([CH:16]2[CH2:21][CH2:20][CH2:19][NH:18][CH2:17]2)[CH:15]=1)[CH2:6][CH:7]([CH3:9])[CH3:8])[CH3:2].BrC[C:35]1[CH:44]=[CH:43][C:38]2[N:39]([CH3:42])[N:40]=[N:41][C:37]=2[CH:36]=1.[CH:45](N(C(C)C)CC)(C)C.CN(C=O)C>CC#N.CCOC(C)=O>[CH2:1]([O:3][C:4](=[O:32])[CH:5]([C:10]1[CH:11]=[C:12]([C:22]2[CH:23]=[CH:24][C:25]([C:28]([F:29])([F:30])[F:31])=[CH:26][CH:27]=2)[CH:13]=[C:14]([CH:16]2[CH2:21][CH2:20][CH2:19][N:18]([CH2:45][C:44]3[CH:35]=[CH:36][C:37]4[N:41]=[N:40][N:39]([CH3:42])[C:38]=4[CH:43]=3)[CH2:17]2)[CH:15]=1)[CH2:6][CH:7]([CH3:9])[CH3:8])[CH3:2]참가 물질
7
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
To a solution of compound 33b, 4-Methyl-2-(5-piperidin-3-yl-4′-trifluoromethyl-biphenyl-3-yl)-pentanoic acid ethyl ester (52.6 mg, 0.118 mmol) in CH3CN (5 ml) was added 5-(Bromomethyl)-1-methyl-1H-1,2,3-benzotriazole (40.0 mg, 0.18 mmol), diisopropylethylamine (41 μl, 0.24 mmol) and DMF)(0.3 ml) to solubolize. The reaction was microwaved at 130° C. for 40 minutes, then at 150° C. for 1 hour 10 min. The reaction was diluted with EtOAc and washed with brine, sat. NaHCO3, and brine, dried and filtered. Purification by silica gel chromatography (Isco) gave the desired product, (67 mg, 96%). Calcd for C33H39F3NO4 (M+H) 592.69, Found 593.4.
후처리
- customThe reaction was microwaved at 130° C. for 40 minutes
- washwashed with brine, sat. NaHCO3, and brine
- customdried
- filtrationfiltered
- customPurification by silica gel chromatography (Isco)
출처 및 근거
- ORD 기록
- ord-eac4ebb069eb48e0b5d20a2c505609d9
- 출처 데이터셋
- uspto-grants-2012_08
- 특허 번호
- US08252935B2
반응 노트
불러오는 중…